Cargando…

Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life

BACKGROUND: Along with its high prevalence, the burden of allergic rhinitis rests upon the serious impact on quality of life of patients. Allergic rhinitis is associated with impairments in daily activities, work and school performance, and practical problems. Patients suffer from sleep disorders an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novakova, Silviya Mihaylova, Staevska, Maria Toncheva, Novakova, Plamena Ivanova, Yoncheva, Manuela Dimitrova, Bratoycheva, Maria Stoykova, Musurlieva, Nina Mihaylova, Tzekov, Valeri Dimitrov, Nicolov, Dimitar Georgiev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622572/ https://www.ncbi.nlm.nih.gov/pubmed/28962623 http://dx.doi.org/10.1186/s12955-017-0764-z

Ejemplares similares

Current opinions for the management of asthma associated with ear, nose and throat comorbidities
por: Tiotiu, Angelica, et al.
Publicado: (2018)

Pyrenebutyrate Pt(IV) Complexes with Nanomolar Anticancer Activity
por: Ahmedova, Anife, et al.
Publicado: (2023)

Progress in Occupational Asthma
por: Tiotiu, Angelica I., et al.
Publicado: (2020)

Impact of Air Pollution on Asthma Outcomes
por: Tiotiu, Angelica I., et al.
Publicado: (2020)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

Sublingual immunotherapy for pediatric patients with mite allergies
por: Kajiume, Teruyuki
Publicado: (2022)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites
por: Kim, Ji Hye, et al.
Publicado: (2018)

Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
por: Mihaylova, M, et al.
Publicado: (2017)

Development of a sublingual allergy vaccine for grass pollinosis
por: Frati, Franco, et al.
Publicado: (2010)

Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
por: Dimova, Rositsa, et al.
Publicado: (2019)

487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
por: Alvarez, Mirta, et al.
Publicado: (2012)

Acute systemic reactions to sublingual immunotherapy for house dust mite
por: Janssens, Nicky S., et al.
Publicado: (2020)

Essential elements of a care delivery model for children with neurological impairments during the COVID-19 pandemic: Notes from Bulgaria
por: Nikolova, Silviya Pavlova, et al.
Publicado: (2022)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
por: Proctor, Thomas, et al.
Publicado: (2020)

Phenolic Profile and In vitro Antioxidant Activity of Endemic Bulgarian Carduus Species
por: Dimitrova-Dyulgerova, Ivanka, et al.
Publicado: (2015)

200 Efficacy of Mite Sublingual Immunotherapy in 130 Children with Atopic Dermatitis
por: Tang, Jianping
Publicado: (2012)

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy
por: Aarestrup, Matheus Fonseca, et al.
Publicado: (2021)

Benefit Effect of Sublingual Dust Mite Drops on the Control of Asthma in Children
por: Wang, Li, et al.
Publicado: (2021)

Importance of Quality of Life for Adherence to Sublingual Immunotherapy
por: Lemberg, Marie-Luise, et al.
Publicado: (2016)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites
por: Kim, Shin Hye, et al.
Publicado: (2015)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
por: Vogelberg, Christian, et al.
Publicado: (2020)

Characteristics of dust mite sublingual immunotherapy-associated adverse events in the early phase
por: Chen, Ming, et al.
Publicado: (2022)

Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials
por: Feng, Bohai, et al.
Publicado: (2017)

Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite–Induced Allergic Rhinitis
por: Xie, Shaobing, et al.
Publicado: (2021)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

Risk factors for development of chronic periodontitis in Bulgarian patients (pilot research)
por: Stoykova, Maria, et al.
Publicado: (2014)

Decrements in health‐related quality of life associated with adverse events in people with diabetes
por: Keng, Mi Jun, et al.
Publicado: (2021)

The effect of diabetes complications on health-related quality of life: estimating the bias due to unobserved heterogeneity using the UKPDS
por: Alva, Maria L, et al.
Publicado: (2011)

Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy
por: Rossi, Renato E, et al.
Publicado: (2010)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_phsng209efpnkh6i41qbcl51ur